Medicare's $2,000 prescription drug cap expected to bring major relief to cancer patients [View all]
Source: NBC News
Dec. 25, 2024, 5:00 AM EST
Starting Jan. 1, older adults on Medicare will spend no more than $2,000 a year on prescription drugs when a new price cap on out-of-pocket payments from the Inflation Reduction Act goes into effect. Experts say the change is expected to provide major relief for cancer patients who often struggle to afford their medications due to the high cost of cancer drugs.
Diana DiVito, of Canonsburg, Pennsylvania, recalls the shock she felt after she got her first co-payment for the cancer drug Imbruvica in 2016. The 83-year-old was diagnosed with chronic lymphocytic leukemia, a type of blood cancer that begins in the bone marrow, in 2005. She underwent treatment, including chemotherapy, and went into remission. When she had a recurrence, she started taking Imbruvica.
By 2021, DiVito had spent $56,000 out-of-pocket on the daily pill. The co-pays blew me away, said DiVito, who added shes been on limited income since her husband died in 2023. It started out the first year was $8,500 out of pocket, and then it went up about $1,000 every year after that.
The new price cap will apply to all prescription drugs under Medicare Part D; it wont apply to drugs given to patients in the hospital or other health care settings, such as chemotherapy or anesthesia. Medicare recipients will also have the new option of spreading their payments out over the course of the year, rather than paying a large co-payment all at once.
Read more: https://www.nbcnews.com/health/health-news/medicare-prescription-drug-cap-cancer-relief-january-rcna185251